Olympus stock forecast 2012

Olympus stock forecast 2012 : OLYMPUS CORPORATION announced that it has amended the consolidated full-year forecast for revenue from JPY 900,000 million to an undetermined value, operating profit from JPY 50,000 million to an undetermined value, ordinary profit from JPY 35,000 million to an undetermined value, net profit from JPY 18,000 million to an undetermined value and earning per share from JPY 67.43 to an undetermined value for the fiscal year ending March 31, 2012. This is due to the Company's issue about extraordinary loss recording. The Company has also canceled the mid-year dividend forecast for the fiscal year ending March 31, 2012. The year-end dividend forecast is still undetermined.

Olympus Corporation is engaged in medical, life science, industrial and imaging business. The Company operates in five segments: medical, life sciences and industrial system business, imaging systems business, information and communication business, and other. The Medical Systems Business covers gastrointestinal endoscopes, surgical endoscopes, endotherapy devices, endoscopic ultrasound systems and medical information systems. Olympus offers live cell imaging and bio-imaging technology, which enables the observation of the movements and mechanisms of molecules within living organisms. Olympus offers industrial endoscopes, ultrasonic defect detection devices, eddy current flaw detectors, and x-ray fluorescence and x-ray diffraction analyzers, as well as to contribute to research and development of production sites. Olympus offers products in its digital camera and IC recorder line ups. For the latest updates on the stock market, visit Stock Market Today For the latest updates PRESS CTR + D or visit Stock Market news Today

Related Post: